Quality Culture Drives Patient Confidence in Drug Products

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-15-2019
Volume 2019 eBook
Issue 2
Pages: 4–5

While overall industry performance is trending positive, quality failures continue to negatively impact patients and the bio/pharma industry.

While patients generally trust that the drugs they take are safe, product recalls, drug shortages, reports of potential contaminants, and publicized regulatory enforcement actions can shake public confidence in the drug supply. While FDA looks to encourage voluntary compliance over the “stick” approach of tighter enforcement, bio/pharma companies are encouraged to build a quality culture throughout the organization, starting with top executives at the company.

Read this article in Pharmaceutical Technology’s September 2019 Regulatory Sourcebook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook, September 2019
September 2019
Pages: 4–5

Citation

When referring to this article, please cite it as R. Peters, “Quality Culture Drives Patient Confidence in Drug Products," Pharmaceutical Technology Regulatory Sourcebook eBook (September 2019).

 

Recent Videos
Drug Digest: Strategic Partnerships
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development